Bicycle Therapeutics plc Cash Flow Reinvestment Rate

Latest as of June 2023: 0.02x

Bicycle Therapeutics plc cash flow reinvestment rate. Bicycle Therapeutics plc (50BA) has a Cash Flow Reinvestment Rate of 0.02x as of June 2023, reinvesting €554.00K (capex €277.00K plus investments €-277.00K) from operating cash flow of €34.10 Million. Explore cash flow to debt ratio of Bicycle Therapeutics plc to assess how comfortably operating cash covers total debt obligations.

Reinvestment Rate

0.02x

(Capex + Investments) / Operating CF

Total Reinvested

€554.00K

Capex + Investments

Operating Cash Flow

€34.10 Million

EUR

Capital Expenditures

€277.00K

EUR

Bicycle Therapeutics plc Cash Flow Reinvestment Rate by Year (None–None)

Bicycle Therapeutics plc cash flow reinvestment rate by year from None to None. Year-by-year capital reinvestment analysis for Bicycle Therapeutics plc. For the full cash flow conversion analysis, see Bicycle Therapeutics plc (50BA) cash flow conversion.

Year	Reinvestment Rate	Total Reinvested (EUR)	Operating CF	Capex	YoY Change

Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow